arrow
A

Andrew S. Brohl

Moffitt Cancer Center
H指数:32
被引数:5,552

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression

纳武利尤单抗和雷莫芦单抗在伊匹木单抗和纳武利尤单抗进展后的黑色素瘤脑转移疗效

2026-03-090
PRE
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

可手术切除的增生性黑色素瘤的新辅助PD-1阻滞: SWOG S1512 2期试验的队列A

2026-01-290
OAAI
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node Biopsy

ASO视觉摘要:原发默克尔细胞癌患者行阳性、阴性或未行哨兵淋巴结活检的复发与生存结局

2025-12-080
PRE
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy

原发性 Merkel 细胞癌患者中,根据哨兵淋巴结活检阳性、阴性或未进行的结果分析复发与生存结局

2025-10-300
PRE
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

不可切除的增生性黑色素瘤的Anti-PD-1治疗: SWOG S1512 2期试验

2025-08-140
PRE
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

超过1300例不同组织学亚型的肉瘤的基因组、转录组及免疫基因组景观

2025-05-060
OA
Preliminary results of first-in-human study of 225-Actinium MTI-201 (225Ac-MTI-201) in metastatic uveal melanoma

225-Actinium MTI-201(225Ac-MTI-201)在转移性眼脉络膜黑色素瘤中的首次人体研究初步结果

2024-09-010
PRE
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy
2024-07-261
PRE